Patent · US Active

Trispecific antibodies

US10428155B2 · kind B2 · utility

28Cited by
126References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 22, 2015
Grant dateOct 1, 2019
Priority date—
Expiry dateDec 22, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/626
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides trispecific antibodies that co-engage CD3, CD8 and a tumor target antigen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.